Hospital acquired infections
Diagnostic tests for hospital acquired infections
Hospital acquired infections (HAI) or nosocomial infections
4.1 million people are affected by hospital acquired infections every year in the EU alone. This results in at least 37 000 deaths and an annual economic impact of EUR 7 billion according to the European Centre for Disease Prevention and Control (ECDC). One in eighteen hospitalized patients acquires an infection. Clemedi has recognized the pressing need in this field. A group of pathogens termed ESKAPE pathogens are particularly important. The ESKAPE bacteria are Enterococus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacter spp. Clemedi is developing a reliable detection method for these bacteria in addition to a comprehensive resistance testing against relevant antibiotics. We will address the issue with three main products for urinary tract infection, surgical site infections and ventilator associated pneumonia.
Our product portfolio: